FDA

201 - 220 of 459 Results

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: News You Might Have Missed

    Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare鈥檚 coverage decision for the controversial Alzheimer鈥檚 disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Congress Shelves Covid Funding for Now

    The Biden administration鈥檚 request for billions more in funding to fight covid-19 hit a snag on Capitol Hill this week, as Democrats objected to Republican demands that money allocated to states but not yet spent be reclaimed. Meanwhile, the big annual spending bill about to cross the finish line addresses other health policy changes, such as giving the FDA authority to regulate 鈥渟ynthetic鈥 nicotine. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Jessie Hellmann of Modern Healthcare join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: It鈥檚 Health Costs, Stupid (2022 Edition)

    As the pandemic wanes, for now, the ever-rising cost of health care is again taking center stage. Meanwhile, a year into the Biden administration, the FDA finally has a Senate-confirmed commissioner, Dr. Robert Califf. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet, and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Hannah Wesolowski of the National Alliance on Mental Illness, about how the pandemic has worsened the nation鈥檚 mental health crisis and what can be done about it.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: FDA Takes Center Stage

    Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of 鈥淧DUFA鈥 also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer鈥檚 disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN鈥檚 Julie Rovner to discuss these issues and more.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Paging the HHS Secretary

    Health and Human Services Secretary Xavier Becerra is drawing criticism for his hands-off handling of the covid crisis even though the heads of the Centers for Disease Control and Prevention, National Institutes of Health, and FDA report to him. Meanwhile, the Department of Labor looks to enforce mental health 鈥減arity laws鈥 that have failed to achieve their goals. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico, and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN鈥檚 Noam N. Levey, who reported and wrote the latest KHN-NPR 鈥淏ill of the Month鈥 episode about a large emergency room bill for a small amount of medical care.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Dealing With Drug Prices

    Medicare officials tentatively plan to restrict the use of a controversial Alzheimer鈥檚 drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Oh, Oh, Omicron

    Even before the omicron variant of covid starts to spread widely in the U.S., hospitals are filling up with post-holiday delta cases. Meanwhile, the Supreme Court signals 鈥 loudly 鈥 that 2022 will be the year it rolls back abortion rights in a big way. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Ellen McIntire of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: The Big Biden Budget Bill Passes the House

    President Joe Biden鈥檚 social spending budget is on its way to the U.S. Senate, where Democratic leaders are (optimistically) hoping to complete work by the end of the year. Meanwhile, covid is surging again in parts of the country, along with the political divides it continues to cause. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins School of Public Health, and Mary Agnes Carey of KHN join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner previews next week鈥檚 Supreme Court abortion oral arguments with Florida State University law professor Mary Ziegler.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Boosting Confusion

    Federal health officials appear poised to extend a recommendation for covid boosters to all adults, following moves by some governors and mayors to broaden the eligible booster pool as caseloads rise. Meanwhile, the Food and Drug Administration finally has a nominee to head the agency: former FDA chief Robert Califf. And Medicare premiums for consumers will likely rise substantially in 2022, partly due to the approval of a controversial drug to treat Alzheimer鈥檚 disease. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann, host of the 鈥淎n Arm and a Leg鈥 podcast.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Biden Social-Spending 鈥楩ramework鈥 Pulls Back on Key Health Pledges

    President Joe Biden unveiled a compromise 鈥淏uild Back Better鈥 framework shortly before taking off for key meetings in Europe, but it鈥檚 unclear whether the framework can win the votes of all Democrats in the House and Senate, and it leaves out some of the party鈥檚 health priorities, notably significant provisions to lower prescription drug prices. Meanwhile, younger children may soon be eligible for covid vaccines. Joanne Kenen of Politico and Johns Hopkins, Sarah Karlin-Smith of the Pink Sheet and Rachana Pradhan of KHN join KHN鈥檚 Julie Rovner to discuss these issues and more.